Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEGI for Hypertensive Intracerebral Hemorrhage
NCT03546283Phase 3Unknown
- Start
- Jun 2018
- Primary completion
- Jul 2020
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cerebroside + carnosine in intraparenchymal hematoma (IPH). Status: unknown.
02
Drugs
cerebroside + carnosine
03
Conditions
intraparenchymal hematoma (IPH)
Beyond the preview
Go deeper on NCT03546283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03546283.